MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Let’s Talk Medtech

Plotting a Path for Tissue Reconstruction

Image courtesy of Tissium IMG_2023-1-29-182752.jpg
Tissium's co-founder and Chief Innovation Officer, Maria Pereira chronicles her journey into healthcare and how a plan to mend heart tissue led to the formation of a company.

Tissium was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. The company has made tremendous strides since it began. 

Currently, the Company has a pipeline of seven products across three verticals, including sutureless nerve repair, hernia repair and cardiovascular sealants. Each product is designed to enhance the tissue reconstruction process in a unique way. In addition, the company develops complementary delivery and activation devices for enhanced performance and usability of its products.

Tissium's co-founder and Chief Innovation Officer, Maria Pereira spoke to Let's Talk Medtech about the company's success and many of the hurdles and challenges it was facing.  You can listen to the conversation below. 



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.